Insulin lispro biosimilar (Valin Technologies)

赖脯胰岛素生物类似药 (Valin Technologies)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin lispro biosimilar (Valin Technologies)
Drug Alias Name赖脯胰岛素生物仿制药（Valin Technologies）
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValin Technologies
China Registration ClassN/A

Develop Information

Active CompaniesValin Technologies
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB04A10AC04A10AD04
Related LinksN/A